“Modulazione farmacologica dell’omeostasi della Nicotinamide Dinucleotide (NAD+) come approccio terapeutico innovativo per il trattamento dell’insulto renale acuto” Progetto finanziato dalla Regione…
As highlighted in Nature Reviews Nephrology by Prof. John Kellum (Center for Critical Care Nephrology, Univ. of Pittsburgh) in his…
Publishing in Nature, scientists lead Johan Auwerx at EPFL (Lausanne) and Roberto Pellicciari at TES Pharma have found a new…
TES Pharma announces the publication of a Nature paper “De novo NAD+ synthesis enhances mitochondrial function and improves health” (DOI: 10.1038/s41586-018-0645-6)…
Progetto finanziato dalla Regione Umbria nel quadro del “Bando a sostegno dei progetti complessi di ricerca & sviluppo - POR FESR 2014-2020”.…
TES Pharma announces the publication of a Journal of Medicinal Chemistry paper “α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of…
TES announces the successful awarding of a European Regional Development Fund, Umbria project, "Integrated platform for innovative drug research and…
TES Pharma and EPFL announce a new research and development collaboration on novel small molecule modulators of the kynurenine pathway…